BrightPath Biotherapeutics Co.,Ltd. Stock Forecast
Explanation to Bollinger's Bands
Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.
Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.
Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation
BandWidth defines the current width of the band.
%b defines the current position within the band.
BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)
Live Samples:
Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.
Source: http://www.bollingerbands.com
Stronger technical forecast for BrightPath Biotherapeutics Co.,Ltd. stock price after Friday trading.
(Updated on Jun 14, 2024)
The BrightPath Biotherapeutics Co.,Ltd. stock price gained 4.92% on the last trading day (Friday, 14th Jun 2024), rising from JP¥61.00 to JP¥64.00. During the last trading day the stock fluctuated 8.33% from a day low at JP¥60.00 to a day high of JP¥65.00. The price has risen in 6 of the last 10 days and is up by 10.34% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 984 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately JP¥78.28 million.
Given the current short-term trend, the stock is expected to fall -7.69% during the next 3 months and, with a 90% probability hold a price between JP¥48.71 and JP¥59.08 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
4594.T Signals & Forecast
Mostly positive signals in the chart today. The BrightPath Biotherapeutics Co.,Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at JP¥62.14 and JP¥59.51. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 14.29%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for BrightPath Biotherapeutics Co.,Ltd. stock
BrightPath Biotherapeutics Co.,Ltd. finds support from accumulated volume at JP¥62.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved JP¥5.00 between high and low, or 8.33%. For the last week, the stock has had daily average volatility of 4.63%.
Our recommended stop-loss: JP¥61.73 (-3.54%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from a pivot bottom found 74 days ago.)
Trading Expectations (4594.T) For The Upcoming Trading Day Of Monday 17th
For the upcoming trading day on Monday, 17th we expect BrightPath Biotherapeutics Co.,Ltd. to open at JP¥63.00, and during the day (based on 14 day Average True Range), to move between JP¥61.42 and JP¥66.58, which gives a possible trading interval of +/-JP¥2.58 (+/-4.04%) up or down from last closing price. If BrightPath Biotherapeutics Co.,Ltd. takes out the full calculated possible swing range there will be an estimated 8.07% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at JP¥65.00 (1.56%) than the support at JP¥62.00 (3.13%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is BrightPath Biotherapeutics Co.,Ltd. stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.
Current score: 3.134 Buy Candidate Upgraded
Predicted Opening Price for BrightPath Biotherapeutics Co.,Ltd. of Monday, June 17, 2024
| Fair opening price June 17, 2024 | Current price |
|---|---|
| JP¥63.00 ( 1.56%) | JP¥64.00 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for 4594.T
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 68.00 | 6.25% |
| R2 | 66.09 | 3.27% |
| R1 | 64.91 | 1.42% |
| Price | 64.00 | |
| S1 | 61.09 | -4.55% |
| S2 | 59.91 | -6.39% |
| S3 | 58.00 | -9.38% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 67.00 | 4.69% |
| R2 | 66.00 | 3.13% |
| R1 | 65.00 | 1.56% |
| Price | 64.00 | |
| S1 | 62.00 | -3.13% |
| S2 | 59.00 | -7.81% |
| S3 | 58.00 | -9.38% |
FAQ
Click here for our free guide on how to buy BrightPath Biotherapeutics Co.,Ltd. Stock.
